| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,925 | 26,262 | 24,575 | 25,748 | | Cost of Revenue | 7,993 | 8,651 | 9,366 | 10,043 | | | Gross Profit |
-
| 17,611 | 15,209 | 15,705 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,592 | 7,927 | 7,246 | 7,151 | | Non Recurring |
-
| 30,363 |
-
| (3,922) | | Others | 2,289 | (23,952) | 22,568 | 7,111 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,273 | (14,605) | 5,365 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,051 | 3,273 | (14,605) | 5,365 | | Interest Expense | 2,711 | 2,691 | 2,702 | 2,470 | | Income Before Tax | 340 | 582 | (17,307) | 2,895 | | Income Tax Expense | (515) | (776) | (3,237) | 830 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 855 | 1,358 | (14,070) | 2,065 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 855 | 1,358 | (14,070) | 2,065 | | Preferred Stock And Other Adjustments | (397) | (397) | (432) |
-
| | | Net Income Applicable To Common Shares | $458 | $961 | ($14,502) | $2,065 |
|
0.40% Nasdaq 
0.49 (7.10%) 
Income Statement
